Friday, March 20, 2026 3/20/2026

Institutional Career Development Core

Award Number: KL2TR002381
ORGANIZATION: NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES
OPDIV: NIH
AWARD CLASS: DISCRETIONARY
AWARD ACTIVITY TYPE: SOCIAL SERVICES
PERIOD OF PERFORMANCE START DATE: 09/22/2017
PERIOD OF PERFORMANCE END DATE: 07/31/2027

Group Awards By:

View Award Description

Institutional Career Development Core - The KL2 Core is an essential component of the Georgia Clinical & Translational Science Alliance (Georgia CTSA) and is designed to respond to the critical needs of training a new generation of clinical and translational research (CTR) investigators who will carry out high impact research and translate new discoveries to improve health outcomes and advance public health. The Georgia CTSA KL2 Core is closely linked with our TL1 Core, and both programs are governed by a joint KL2-TL1 Research Education Executive Committee. The KL2 Core is focused on enhancing career development of junior faculty (Instructor or Assistant Professor level with either MD, PharmD, and/or PhD degrees) with substantial potential to become successful and transformative biomedical researchers at the Georgia CTSA partner institutions (Emory University, Morehouse School of Medicine, Georgia Institute of Technology [Georgia Tech], and the University of Georgia). A solid foundation has been established for the KL2 Core over the past 14 years. Our KL2 program has supported 60 scholars (including 26 during the current cycle of funding. Among the 46 scholars who have completed training, 43 (93%) remain in careers engaged in CTR; 70% of our former KL2 scholars have gone on to obtain federal funding as PI; and 6 former KL2 scholars have assumed leadership positions in Georgia CTSA. The KL2 Core also provides critical didactic and mentored CTR training infrastructure for KL2 scholars and other trainees at the 4 partner institutions through support of the Master of Science in Clinical Research (MSCR) program and the Certificate Program in Translational Science (CPTS). The development of online/virtual training for the MSCR and CPTS programs (necessitated by the COVID-19 pandemic) enables us to expand the reach of these successful CTR training programs across the partner institutions. In the next funding cycle, we will expand personalized training pathways and provide scholars with the skills to conduct CTR that addresses significant public health challenges. We aim to broaden participation in the KL2 program across partner institutions and facilitate career development to help ensure scholars are equipped to serve in a range of research and leadership settings. We will also fully implement an expanded K-ADVANCE (K to R mentoring) program for former scholars and other trainees. A comprehensive evaluation plan will continue to measure the impact of our KL2 Core activities and provide evidence-based data to make midcourse corrections, as needed. Specific aims include: 1) To promote and enhance personalized career development of junior faculty across the 4 partner institutions; 2) To continue to support and innovate the successful Georgia CTSA MSCR and CPTS programs which provide didactic and mentored CTR training to KL2 scholars and other trainees; and 3) To enhance mentorship training and enrich “influential mentoring” activities for the next generation of CTR investigators through evidence-informed approaches that prepare mentors to effectively support the career development of the next generation of CTR investigators.


Issue Date FY	Funding FY	Legal Entity Name	Legal Entity Address	Legal Entity City	Legal Entity State	Legal Entity Zip Code	Legal Entity COUNTY	Legal Entity COUNTRY	Assistance Listing	Award Code	Budget Year	Action Date	Action Type	Action Amount

Issue Date FY: 2026 ( Subtotal = $0 )
2026	2025	EMORY UNIVERSITY	201 DOWMAN DR NE	ATLANTA	GA	30322	DEKALB	USA	National Center for Advancing Translational Sciences	000	9	2/13/2026	NON-COMPETING CONTINUATION	$0
														Subtotal = $0

Issue Date FY: 2025 ( Subtotal = $1,525,261 )
2025	2025	EMORY UNIVERSITY	201 DOWMAN DR NE	ATLANTA	GA	30322	DEKALB	USA	National Center for Advancing Translational Sciences	000	9	8/9/2025	NON-COMPETING CONTINUATION	$1,525,261
2025	2025	EMORY UNIVERSITY	201 DOWMAN DR NE	ATLANTA	GA	30322	DEKALB	USA	National Center for Advancing Translational Sciences	001	9	8/27/2025	NON-COMPETING CONTINUATION	$0
														Subtotal = $1,525,261

Issue Date FY: 2024 ( Subtotal = $1,525,261 )
2024	2024	EMORY UNIVERSITY	201 DOWMAN DR NE	ATLANTA	GA	30322	DEKALB	USA	National Center for Advancing Translational Sciences	002	8	8/9/2024	NON-COMPETING CONTINUATION	$1,525,261
2024	2022	EMORY UNIVERSITY	201 DOWMAN DR NE	ATLANTA	GA	30322	DEKALB	USA	National Center for Advancing Translational Sciences	001	6	7/30/2024	COMPETING CONTINUATION	$71,316
2024	2021	EMORY UNIVERSITY	201 DOWMAN DR NE	ATLANTA	GA	30322	DEKALB	USA	National Center for Advancing Translational Sciences	000	5	7/30/2024	NON-COMPETING CONTINUATION	-$71,316
														Subtotal = $1,525,261

Issue Date FY: 2023 ( Subtotal = $1,525,261 )
2023	2023	EMORY UNIVERSITY	201 DOWMAN DR	ATLANTA	GA	30322	DEKALB	USA	National Center for Advancing Translational Sciences	000	7	8/2/2023	NON-COMPETING CONTINUATION	$1,525,261
														Subtotal = $1,525,261

Issue Date FY: 2022 ( Subtotal = $1,531,261 )
2022	2022	EMORY UNIVERSITY	201 DOWMAN DR	ATLANTA	GA	30322	DEKALB	USA	National Center for Advancing Translational Sciences	001	6	8/31/2022	COMPETING CONTINUATION	$1,531,261
2022	2021	EMORY UNIVERSITY	201 DOWMAN DR	ATLANTA	GA	30322	DEKALB	USA	National Center for Advancing Translational Sciences	000	5	8/23/2022	NON-COMPETING CONTINUATION	$0
														Subtotal = $1,531,261

Issue Date FY: 2021 ( Subtotal = $1,300,308 )
2021	2021	EMORY UNIVERSITY	201 DOWMAN DR	ATLANTA	GA	30322	DEKALB	USA	National Center for Advancing Translational Sciences	000	5	6/29/2021	NON-COMPETING CONTINUATION	$1,300,308
														Subtotal = $1,300,308

Issue Date FY: 2020 ( Subtotal = $1,300,308 )
2020	2020	EMORY UNIVERSITY	201 DOWMAN DR	ATLANTA	GA	30322	DEKALB	USA	National Center for Advancing Translational Sciences	000	4	6/23/2020	NON-COMPETING CONTINUATION	$1,300,308
														Subtotal = $1,300,308

Issue Date FY: 2019 ( Subtotal = $1,300,308 )
2019	2019	EMORY UNIVERSITY	1599 CLIFTON RD.	ATLANTA	GA	30322	DEKALB	USA	National Center for Advancing Translational Sciences	000	3	7/30/2019	NON-COMPETING CONTINUATION	$1,300,308
														Subtotal = $1,300,308

Issue Date FY: 2018 ( Subtotal = $1,301,416 )
2018	2018	EMORY UNIVERSITY	1599 CLIFTON RD.	ATLANTA	GA	30322	DEKALB	USA	National Center for Advancing Translational Sciences	000	2	7/24/2018	NON-COMPETING CONTINUATION	$1,301,416
														Subtotal = $1,301,416

Issue Date FY: 2017 ( Subtotal = $1,305,199 )
2017	2017	EMORY UNIVERSITY	1599 CLIFTON RD.	ATLANTA	GA	30322	DEKALB	USA	National Center for Advancing Translational Sciences	000	1	9/22/2017	NEW	$1,305,199
														Subtotal = $1,305,199

Grand Total All Awards = $12,614,583

Top

All Categories

About

Search

Reports

Data Submission

Award Information

Institutional Career Development Core

Award Number: KL2TR002381

ORGANIZATION: NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES

OPDIV: NIH

AWARD CLASS: DISCRETIONARY

AWARD ACTIVITY TYPE: SOCIAL SERVICES

PERIOD OF PERFORMANCE START DATE: 09/22/2017

PERIOD OF PERFORMANCE END DATE: 07/31/2027

Federal Websites

Department of Health & Human Services

HHS Operating Divisions

HHS Staff Divisions

Download A Document Viewer